FDA NDC Directory · JSON-LD · Markdown

KANUMA

NDC 25682-007 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameSebelipase alfa
Labeler / ManufacturerAlexion Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA125561
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsSEBELIPASE ALFA (2 mg/mL)
Marketing started20151208
Package count1

External sources

Source: openFDA. Public-domain (CC0).